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Chemokines are small (8–12 kDa) effector proteins that potentiate leukocyte chemonavigation. Beyond this role, certain chemokines have
direct antimicrobial activity against human pathogenic organisms; such molecules are termed kinocidins. The current investigation was designed
to explore the structure–activity basis for direct microbicidal activity of kinocidins. Amino acid sequence and 3-dimensional analyses
demonstrated these molecules to contain iterations of the conserved γ-core motif found in broad classes of classical antimicrobial peptides.
Representative CXC, CC and C cysteine-motif-group kinocidins were tested for antimicrobial activity versus human pathogenic bacteria and
fungi. Results demonstrate that these molecules exert direct antimicrobial activity in vitro, including antibacterial activity of native IL-8 and MCP-
1, and microbicidal activity of native IL-8. To define molecular determinants governing its antimicrobial activities, the IL-8 γ-core (IL-8γ) and α-
helical (IL-8α) motifs were compared to native IL-8 for antimicrobial efficacy in vitro. Microbicidal activity recapitulating that of native IL-8
localized to the autonomous IL-8α motif in vitro, and demonstrated durable microbicidal activity in human blood and blood matrices ex vivo.
These results offer new insights into the modular architecture, context-related deployment and function, and evolution of host defense molecules
containing γ-core motifs and microbicidal helices associated with antimicrobial activity.
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Chemokines comprise a class of small secretory cytokines
that play important roles in potentiating leukocyte chemonavi-
gation and host defense activity. More than 40 human
chemokines have been characterized and are classified into
four groups according to conserved N-terminal cysteine motifs:
CXC (α-chemokines), CC (β-chemokines), C, and CX3C.
Chemokines have been identified in vertebrates as distant as
teleost fish, and are expressed in a broad array of mammalian
cell types including myeloid, endothelial, epithelial and
fibroblast lineages [1]. Of the chemokines, interleukin-8 (IL-
8; or CXC-ligand 8 [CXCL8]) is perhaps the best characterized,
having been first identified as neutrophil-activating factor from
human monocytes more than 15 years ago [2,3].
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classical antimicrobial peptides. Like chemokines, antimicro-
bial peptides are typically small, amphipathic, and cationic
effectors of innate immunity, and are found in organisms across
the phylogenetic spectrum [4]. Moreover, many chemokines
and antimicrobial peptides are expressed at low levels in
unstimulated host cells, but are rapidly upregulated 10- to 100-
fold upon exposure to relevant stimuli, including microbial
components [1]. The fact that certain antimicrobial peptides are
chemotactic reinforces further functional reciprocity between
antimicrobial peptides and chemokines [5]. Duality in micro-
bicidal and chemokine functions of such host defense peptides
suggests important biological links between classical antimi-
crobial peptides and microbicidal chemokines, as well as
molecular and cellular innate immune responses.
While chemokines have not traditionally been ascribed with
direct antimicrobial activities, evidence for such functions is
mounting. Direct antimicrobial efficacy has been demonstrated
for the platelet chemokines PF-4, platelet basic peptide (PBP)
and its derivative CTAP-3 [6–8], and truncations thereof [9].
Direct antimicrobial activity has also recently been confirmed
for other chemokines [10,11]. Hence, the term kinocidin
(kino—chemokine; cidin—microbicidal) has been applied to
encompass chemokines with direct microbicidal activity
[4,8,12]. Despite immunological likeness to other kinocidins,
the direct antimicrobial activity of well-characterized chemo-
kines such as IL-8 has only recently been recognized [4,12–14].
For example, although Bjorstad et al. described antibacterial
activity of an IL-8-derived peptide [14], their studies did not
demonstrate antimicrobial activities of native (full-length) IL-
8 in vitro, or microbicidal efficacy of these molecules in human
blood or blood matrices. Thus, the present investigations were
conducted to seek new insights into the antimicrobial structures
and functions of human kinocidins, including IL-8.
The current studies provide important new information
regarding complementary host defense roles of kinocidins.
Primary sequence and 3-dimensional analyses revealed that
kinocidins possess iterations of the hallmark γ-core signature
present in broad classes of cysteine-stabilized antimicrobial
peptides and other host defense effector proteins [4]. Moreover,
current data demonstrate diverse kinocidins exert differential
antimicrobial efficacies and spectra under pH conditions
pertinent to infection and inflammation. These findings support
our hypothesis that certain kinocidins are evolved to exert
optimal host defense functions in specific contexts [4,12,13].
Synthetic congeners corresponding to α-helical and γ-core
domains of IL-8 distinguished the direct versus indirect
antimicrobial functions of these respective modules. Moreover,
these studies revealed a previously undetected direct fungicidal
activity of the IL-8 helix versus Candida albicans. Collectively,
these results demonstrate that human kinocidins contain
iterations of γ-core motifs present in classical antimicrobial
peptides, configured with α-helical motifs that likely mediate
their antimicrobial activity. These motifs are integrated in a
modular form within kinocidins, facilitating autonomous
dissociation of the helix to exert microbicidal efficacy in
relevant contexts of blood matrices.2. Materials and methods
2.1. Native molecules
Recombinant human chemokines (IL-8, RANTES, GRO-α, MCP-1, PF-4,
and lymphotactin [Biosource International, Camarillo, CA]), and human
neutrophil defensin-1 (HNP-1 [Peptides International, Louisville, KY]) were
obtained commercially.
2.2. Peptide synthesis and authentication
IL-8 structural domains were generated by F-moc solid-phase synthesis: γ-
core (ANTEIIVKLSDGRELCLDP; IL-8γ), and α-helix (KENWVQRV-
VEKFLKRAENS; IL-8α). Peptides were purified by RP-HPLC as previously
described ([15]; >95% purity), and authenticated by amino acid analysis
(Molecular Structure Facility, University of California, Davis) andMALDI-TOF
spectrometry (UCLA Spectrometry Facility). Experimentally determined
masses were within standard confidence intervals (<±0.1% of calculated
molecular weight).
2.3. Antimicrobial assays
Antimicrobial assays were performed against a panel of prototype human
pathogens as previously detailed [4]: Staphylococcus aureus (ATCC 27217;
Gram-positive bacterium); Salmonella typhimurium (5996s; Gram-negative
bacterium); and the fungus Candida albicans (ATCC 36082). All assays were
conducted a minimum of two independent times with multiple replicates.
Results of independent assays were analyzed using Wilcoxon Rank Sum
analysis with Bonferroni correction for multiple comparisons.
2.3.1. Solid-phase assay
Mid-logarithmic phase organisms were prepared, introduced into buffered
agarose (PIPES [10 mM, pH 7.5] or MES [2.0 mM, pH 5.5]) to achieve final
inocula of 106 CFU/ml, and poured into plates. Peptides (0.5 nmol/well
[50 nmol/ml]) were added to wells in the seeded matrix, and incubated for
3 h at 37 °C. Nutrient overlay medium was applied, and assays incubated at
37 °C or 30 °C for bacteria or fungi, respectively. After 24 h, zones of
inhibition were measured, and results recorded as zones of complete or
partial inhibition. Defensin HNP-1 was included in each assay as an internal
control. Zones of inhibition were measured in millimeters as the radius of the
cleared region minus the well diameter. This assay reflects microbiostatic
(inhibition) and/or microbicidal (killing) activities, but does not distinguish
these effects.
2.3.2. Solution-phase assay
Organisms were prepared and adjusted to 106 CFU/ml in PIPES or MES
buffer as above but lacking agarose, and dispensed (5×104 CFU per 50 μl
aliquot). Peptide (concentration range, 20–0.00125 nmol/ml) was introduced
into the assay medium, and incubated for 1 h at 37 °C. After incubation, media
were serially diluted and plated in triplicate for enumeration.
2.3.3. Biomatrix assay
Antimicrobial activity of IL-8α in human whole blood and homologous
plasma and serum fractions was assessed in an ex vivo biomatrix assay
developed to assess antimicrobial polypeptide efficacy in complex human blood
matrices [16]. For biomatrix studies, the well-characterized Escherichia coli
strain ML-35 was used as the target organism in this system [16]. This strain is
resistant to serum, ideal for use in assessing peptide antimicrobial activity in
blood and blood-derived matrices [16]. Organisms were cultured to mid-
logarithmic phase in brain–heart infusion broth (Difco Laboratories, Detroit,
Mich.) at 37 °C, washed, and resuspended in PBS (Irvine Scientific; pH 7.2).
Inocula were quantified spectrophotometrically and validated by quantitative
culture. Biomatrices (whole blood, plasma, or serum) were distributed in 85-μl
aliquots into 96-well microtiter plates (Corning Glass Works, Corning, N.Y.)
Peptide (5 μl; concentration range 1–50 μg/ml) was added either simultaneously
with the microorganism (final inoculum, 105 CFU/ml in a 10 μl volume), or after
a 120 min pre-incubation period in the biomatrix to assess durability of peptide
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(MHB) per guidelines of the Clinical Laboratory Standards Institute [17]. The
mixtures were incubated with constant agitation for 2 h at 37 °C. After
incubation, aliquots were diluted and quantitatively cultured in triplicate onto
blood agar. Surviving organisms were enumerated as CFU/ml. Experiments
were performed a minimum of two independent times on different days and with
different blood donor sources.
2.4. Structure analyses
Complementary methods were used to analyze polypeptide structures in this
investigation:
2.4.1. Bioinformatics
Protein structure data were obtained from the National Center for
Biotechnology Information (NCBI), and visualized using Protein Explorer
[18]. Multiple sequence alignments were performed using Clustal [19] and 3-
dimensional structures were analyzed and visualized using Protein Explorer
[18]. Structural alignments were carried out using combinatorial extension, as
quantified by root mean square deviation (RMSD) analysis [20].
2.4.2. Spectrometry
Secondary structures of IL-8 peptide domains were assessed by circular
dichroism (CD) as previously noted [21]. Spectra were recorded with an AVIV
62DS spectropolarimeter (Aviv Biomedical Inc.). In brief, the purified peptides
were solubilized (50 μg/ml in 50 mM NH4HC03; pH 5.5 or 7.5) and scanned
using a 0.1-mm light path from 260 to 185 nm (rate, 10 nm/min; sample interval,
0.2 nm; 25 °C). A mean of 8 buffer-subtracted spectra were deconvoluted into
helix, β-sheet, turn, and extended structures using Selcon [22] and Dichroweb
[23];cryst.bbk.ac.uk/cdweb) as indicated [21,24,25].Fig. 1. Alignment of C, CC and CXC class human chemokines. The highlighted
corresponds to the γKC core signature (outlined in red). Conserved cysteine residues
alignment; * Indicates truncated sequence.2.4.3. Computational modeling
Three-dimensional models of IL-8 domains were created using comple-
mentary methods [8]. Homology [SWISSMODEL, BLAST2P; [26,27]],
dynamic alignment (SIM) [28] and refined match (ProModII) algorithms were
used to identify modeling templates. In a parallel strategy, IL-8 amino acid
sequences were converted to putative solution conformations by threading
methods (Matchmaker [[29]]; Gene-Fold [[30]]) implemented with SYBYL
software (Tripos Associates, St. Louis, MO). Target conformers were refined
using AMBER95 force field and molecular dynamics [31]. In alternative
approaches, molecular dynamics were executed without 0.4 kJ constraint
penalties for canonical Ramachandran ϕ and ψ angles.3. Results
3.1. Iterations of the γ-core motif in human kinocidins
A bioinformatics approach was used to specify and compare
phylogeny and structural homology in human kinocidins [4].
Sequence and 3-dimensional analyses of more than 30 human C,
CC, and CXC kinocidins demonstrated iterations of antimicro-
bial peptide γ-core motifs [γAP; [4,32]], and that the central β-
sheet domain comprising this motif corresponds to the most
highly conserved domains within mature kinocidins (Fig. 1).
Congruent with the γAP motif, the kinocidin γ-core [γKC core;
[32]] motif is comprised of a 13–17 residue anti-parallel β-
hairpin, containing a central hydrophobic region that is typicallyGX3C motif [glycine (G), orange; cysteine (C), yellow; proline (P), aqua]
beyond the γKC core are shaded gray. Gaps were introduced to achieve maximal
Table 1
Comparative physicochemical properties of human kinocidins and α-helical domains thereof
Classification schema Native molecule α-Helical domain
Class Ligand ID Name AA M Q pI AAα Qα Mα pIα Hα
CXC CXCL8 IL-8 71 8299 +4 9.0 17 +2 2103 10.0 6.70
CXC CXCL4 PF-4 70 7769 +3 8.8 13 +3 1573 9.8 6.12
CXC CXCL1 GRO-α 72 7751 +6 9.5 16 +2 1843 9.6 4.71
CC CCL2 MCP-1 76 8685 +6 9.4 19 0 2287 6.8 5.35
CC CCL5 RANTES 68 7851 +5 9.2 13 0 1655 6.1 6.71
C CL1 Lymphotactin 92 10,173 +9 10.6 14 +2 1735 10.7 3.73
Physicochemical parameters are abbreviated for the native or α-helical domain (α): AA, amino acids; M, average mass (in Daltons); Q, calculated charge at pH 7.0; pI,
estimated isoelectric point [54]; H, hydrophobic moment [55].
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seen in the γAP core is modified such that a GX3C pattern is often
observed within the central β-sheet domain. The following
sequence formula can be used to describe the γKC motif found in
the vast majority of all kinocidins:
NH2⋯½C  ½X10–13  ½GX3C  ½X2  ½P⋯COOH
Exceptions to this consensus formula can be noted in support
of the rule. In some cases, there is variability at the G position,
with the most common substitutions being a cationic (K, R) or
amidated (Q, N) residue. This finding is consistent with
concentration of positive charge propensity as has been
identified in the γ-core motif of antimicrobial peptides [4]. In
two instances (CXCL4 [PF-4], CCL1 [I-309]), the ultimate
proline residue is absent, and in one case (XCL1 [LYM]) the
initial cysteine is deleted. Nonetheless, all known kinocidins
contain a γ-core sequence signature or iteration (Fig. 1).
Human IL-8 contains the sequence: NH2⋯CANTEIIVKLS-
DGRELCLDP⋯COOH. This sequence is consistent with the
consensus γKC-core motif. Furthermore, many kinocidins
exhibit similar physicochemical properties (Table 1) and a
recurring amino acid position pattern adhering to the consensus
γKC core formula (Table 2).3.2. Comparative antimicrobial activities of CXC, CC, and C
group kinocidins
To compare their relative antimicrobial activities, prototypic
members of the CXC, CC, and C-group kinocidins were
evaluated versus a panel of prototypic pathogens in three
distinct but complementary assays:Table 2
Biochemical consensus patterns in human kinocidin primary structures
Signature [C] [X10–13]
Pattern C X3 X X3 X0–2 X
Residue(s) C A/G/E/Q (Z)3 K/R
Frequency 97 100 >97 81
Recurring patterns in amino acid residue are summarized relative to position in kinoci
residue(s) are indicated, along with their percent frequency. Z represents the hydroph
H, K, N, R, Q, S, T; C, P, or G correspond to cysteine, proline, or glycine, respectively;
several variable positions (e.g., the hydrophobic triad [Z3] motif in the [X10–13] d
frequencies of conservation at multiple positions in the γ-core iterations, along wit
kinocidins, antimicrobial peptides, peptide toxins, etc. [4,32]) imply a broader biolo3.2.1. Solid-phase assay
The antimicrobial activities of study kinocidins were
compared in a sensitive and pH-specific radial diffusion
assay [4] (Fig. 2). Each of the representative kinocidins
studied had direct antimicrobial activity in one or more
conditions tested in this assay system (Fig. 3). It is also
significant to note the diversity of antimicrobial spectra and
conditional optima for distinct kinocidins (Fig. 3). In many
cases, kinocidins exerted pathogen- or pH-specific activities
that differed from those of the classical antimicrobial
peptide, HNP-1. Although study kinocidins had pI values
≥8.5 (Table 1), neither net charge nor pI directly
correlated with antimicrobial activity. For example, IL-
8 was one of the least cationic molecules studied (pI=9.0),
but had greater efficacy than many of its more cationic
counterparts.
3.2.2. Solution-phase assay of native IL-8
Patterns of antimicrobial efficacy seen in diffusion assays
of study kinocidins prompted further studies to examine
microbicidal activity. Native (full-length) human IL-8 was
selected as a prototype to characterize its microbicidal
efficacy at pH 5.5 and 7.5 versus the pathogen panel. IL-
8 was highly fungicidal for C. albicans, achieving a five-log
reduction in surviving CFU with 2.5 nmol/ml (20 μg/ml)
peptide at pH 5.5 within 1 h (Fig. 4). IL-8 was also fungicidal
for C. albicans at pH 7.5, with a 2-log reduction in surviving
CFU over 1 h at a concentration of 2.5 nmol/ml. Interestingly,
IL-8 did not exert microbicidal activity against S. typhimurium
or S. aureus in this assay, suggesting that its efficacies versus
these organisms in solid-phase assay were due to bacteriostatic
effects.[G] [X2–3] [C] [X2] [P]
1–3 G X X2 C P
G/B K/R B Z C Z D/N P
94 72 94 92 100 89 86 94
din γ-core motifs. For each component or position, the most common amino acid
obic residues A, F, I, L, V, W, Y; B represents the charged or polar residues D, E,
X indicates variable residues. Note a striking degree of conservation even within
omain recurs with virtually 100% frequency across all kinocidins). Such high
h the presence of this motif in many classes of host defense polypeptides (e.g.
gical significance.
Fig. 2. Conservation of the γ-core domain (γKC core) within diverse kinocidins.
Recurring iterations of the γKC core motif (red) are indicated with corresponding
sequences (GX3C) denoted in red or gold text. A comparator antimicrobial
peptide (Ah-AMP-1) is also shown to illustrate structural similarities between
the γKC motif and that present in antimicrobial peptides (γAP). Proteins were
visualized using protein explorer [18].
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Synthetic IL-8γ and IL-8α peptides were used to probe for
potential molecular correlates of antimicrobial activity.3.3.1. Solid-phase assay of IL-8 structural domains
IL-8α displayed a spectrum of efficacy virtually indistin-
guishable from that of native IL-8 (Fig. 3). Importantly, the
antimicrobial properties of native IL-8 were recapitulated by IL-
8α in the presence and absence of its corresponding γ-core motif
(IL-8γ), even though IL-8γ alone had no detectable antimicro-
bial efficacy at either pH 5.5 or 7.5. Thus, the antimicrobial
efficacy of paired IL-8α and IL-8γ was equivalent to their
natural context in native IL-8γ.
3.3.2. Solution-phase assay of IL-8 structural domains
In the solution-phase assay, as little as 0.125 nmol/ml
(1.0 μg/ml) of IL-8α achieved a five-log reduction in surviving
C. albicans at pH 5.5 in 1 h exposure (Fig. 4). By mass, the
autonomous IL-8α domain conferred a 10-fold greater activity
than native IL-8 against this organism. The pH specific efficacy
patterns of IL-8α also mirrored those of full-length IL-8 (Fig. 4).
Consistent with data in the solid-phase assay, IL-8γ had no
measurable activity in the solution-phase assay, but did not
impede efficacy of IL-8α.
3.3.3. Ex-vivo biomatrix assay
To assess putative physiological relevance of the observed in
vitro antimicrobial activity of IL-8 and IL-8α, the efficacy of IL-
8α was also tested in the ex vivo biomatrix assay. The E. coli
strain ML-35 strain has been the organism of choice for this
assay, as it is serum-resistant and thus serves as a highly relevant
surrogate marker of infection. Importantly, IL-8α exerted
significant efficacy against E. coli, causing decreases of up to
log 5 CFU/ml at 10 μg /ml peptide (Fig. 5). Greatest efficacy
was seen in whole blood and serum in co-incubation studies,
with less activity in plasma fractions or after 2 h pre-incubation
(Table 3).
3.4. Structure–activity relationships of IL-8γ and IL-8α
domains
To gain insights into their antimicrobial determinants, the
structures of IL-8γ and IL-8α were investigated using
biophysical and computational methods:
3.4.1. Spectrometry
CD spectrometry indicated that IL-8γ and IL-8α recapitulat-
ed structures of corresponding regions in full-length IL-8 (Fig.
6). IL-8γ exhibited spectra consistent with a β-sheet structure,
suggesting it spontaneously adopts a fold similar to that in
native IL-8. Likewise, IL-8α displayed classic double dichroic
minima at 208 and 218 nm, hallmark of α-helices, and
concordant with the corresponding region in IL-8. These data
suggest the forces responsible for secondary structures of these
domains function independently from cysteine-stabilization or
other constraints acting within the native molecule. Moreover,
each structure was stable at pH 5.5 and pH 7.2 (Fig. 6).
3.4.2. Computational modeling
To complement spectrometric studies, 3-D models of IL-8γ
and IL-8α were created using homology and energy-based
Fig. 3. Solid-phase antimicrobial activity of human kinocidins and IL-8 subdomains IL-8α and IL-8γ. Peptides (0.5 nmol) were introduced into wells in agarose plates
buffered with MES (2.0 mM, pH 5.5) or PIPES (10.0 mM, pH 7.5). Antimicrobial activity was assessed as the zone of complete (blue) or partial (red) inhibition around
the well. Abbreviations are: Native IL-8 (IL-8); IL-8α, (α); IL-8γ, (γ); IL-8α+IL-8γ (α+γ); RANTES, (RAN); GRO-α, (GRO); MCP-1, (MCP); lymphotactin,
(LYM); platelet factor-4, (PF4); and HNP-1, (HNP). Histograms are means±SEM (minimum n=2).
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human IL-8 (PDB code, 1IL8). As expected, each peptide
retained secondary structure corresponding to homologous
domains within the native molecule (Fig. 7). The IL-8γ core
motif displayed an anti-parallel β-sheet motif, while the
preferential conformation for IL-8α was a highly stable α-
helical motif comprised of four turns. These structure assign-
ments are strongly supported by favorable empirical energy
functions, equivalent to those of the IL-8 template.
4. Discussion
Chemokines are essential regulators of cellular trafficking
and immune signaling. However, until recently the possibility
that chemokines might have direct roles as antimicrobial
effector molecules had not been systematically investigated.
The realization that mammalian platelets contain kinocidins
[6,7] necessitated an expansion of the physiologic repertoire
of activity for chemokines. These discoveries prompted
investigation into whether other members of the structurally-
conserved chemokine superfamily have direct antimicrobial
effects.Direct antimicrobial activity of kinocidins has been estab-
lished in recent studies [7–11], as has the presence of γ-core
motifs in disulfide-stabilized antimicrobial peptides and other
host defense polypeptides [32]. However, the present studies are
novel in that they identify specific γ-core signatures in
kinocidins, further unifying structure and function in diverse
host defense polypeptide classes. In addition, these studies
provide the first evidence to our knowledge of direct antimicro-
bial activity of MCP-1, affirm our prior observations of the direct
antimicrobial activities of native IL-8 [4,13,32], and reveal
specific antimicrobial optima of these and other kinocidins.
These investigations also provide new information regarding the
direct microbicidal efficacy of native IL-8 and the IL-8α motif in
vitro and in human blood biomatrices ex vivo.
The precise roles of specific amino acid residues comprising
the γ-core motif of antimicrobial effector molecules is not yet
known. Interestingly, several recent studies indicate that certain
residues comprising γ-core motifs can be mutated with no
significant change in antimicrobial efficacy [33–36]. For
example, conversion from folded to linear form by cysteine
deletion did not abrogate in vitro antimicrobial activity in
derivatives of human β-defensin 3 [33,34], or in tachyplesins
Fig. 4. Solution-phase microbicidal activity of native IL-8 and subdomains IL-8α and IL-8γKC. One million CFU of the indicated microorganism per milliliter were
incubated with peptide (0.00125–20.0 nmol/ml) in either MES (2.0 mM, pH 5.5) or PIPES (10.0 mM, pH 7.5) for 1 h at 37 °C. Surviving CFU were enumerated and
are described as change in the initial log10 CFU. ○, S. aureus ATCC 27217; ●, S. typhimurium strain 5990 s; □, C. albicans ATCC 36082. Data are means±SD
(minimum n=2).
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element of the γ-core motif enable formation of a β-bulge
associated with correct folding [37]. Whether similar structure–
function correlates also hold true in kinocidins is not known.
Nonetheless, γ-core motifs in IL-8 and perhaps other kinocidins
may not confer direct antimicrobial activity, or may serve a
scaffold-like role facilitating efficacy of its microbicidal helix
[12,32]. For example, as disulfide-containing host defense
proteins are generated through complex biosynthetic pathways,
γ-core motifs may have primary roles in folding, trafficking, or
deployment of kinocidins, rather than a direct antimicrobial
function.
The fact that the α-helical domain of IL-8 has autonomous
microbicidal function implies that kinocidins are modular in
configuration. Such kinocidins share a common topology
comprised of a central β-sheet domain and α-helix. Likewise,
CS-αβ family antimicrobial peptides. The strong antifungal
activity of IL-8 observed in the current study correlates with its
striking structural resemblance to classical antifungal CS-αβ
antimicrobial peptides of plants and insects, that also contain aγ-core and α-helix [4] (Fig. 2); [4,32]. Alternatively, chemokine
motifs are found in N-terminal domains of kinocidins. Such
modular forms of kinocidins may facilitate proteolytic disas-
sembly in contexts of infection, liberating complementary
functional modules [12].
Investigation of the IL-8α domain revealed a highly ordered
helix. As its helical conformation is highly stable at pH 5.5 and
7.5 (Fig. 6), pH-specific antimicrobial efficacy of IL-8α relies
on parameters other than conformation. The current studies
demonstrate that cationic charge and amphipathicity are
segregated in 3-dimensions over the 19-residue IL-8α domain
(Fig. 7). These findings concur with prior NMR studies [38] of
the IL-8 α-helix region. Its estimated pI of 10 and net charge of
+2 (at pH 7) indicate cationic propensity greater than that of
corresponding domains in most other study kinocidins.
Furthermore, its amphipathicity (6.70; Table 1) is also relatively
high, as hydrophobic moments >3.0 are considered significant
in terms of hydrophobic and hydrophilic amino acid segrega-
tion. It is of particular interest that the IL-8α domain shares
many physicochemical features with classical α-helical
Fig. 5. Antimicrobial efficacy of IL-8α in human blood and blood-derivedmatrices
as compared with artificial media (MHB) at pH 5.5 and 7.2. (A) Co-incubation of
IL-8α and the organism simultaneously added to the test biomatrix or medium; (B)
pre-incubation of IL-8α in biomatrices or media for 2 h at 37 °C prior to
introduction of the organism. The E. coli inocula (INOC) were 105 CFU/ml, and
the threshold of sensitivity was considered 0.3 log10 CFU/ml. Results are
presented as mean±SD of a minimum of two independent experiments.
Fig. 6. Circular dichroism spectroscopy for IL-8 structural domains. The spectra
were determined for the IL-8α (A) and IL-8γ (B) peptides (0.1 mM) in sodium
phosphate (10.0 mM, pH 5.5 [——]) or PIPES (10.0 mM, pH 7.5 [⋯ ⋯ ⋯]) buffer.
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sources such as the magainins [39,40] or LL-37 [41,42]. Many
excellent studies have demonstrated that the cationic and
amphipathic properties of these helical peptides are essential for
microbicidal efficacy [41,43–46]. Future studies will addressTable 3
Structural comparisons among representative human kinocidins
Class Ligand ID Name PDB RMSD Z Aln Gap %ID
CC CCL2 MCP-1 1MCA 0.7 7.1 63 1 25
CXC CXCL4 PF-4 1RHP 1.6 5.7 63 1 37
CXC CXCL1 GRO-α 1MGS 1.6 6.1 66 1 42
C XCL1 Lymphotactin 1J8I 1.6 5.1 55 1 22
CC CCL5 RANTES 1RTO 2.4 3.9 54 8 19
Prototypic kinocidins were aligned with human IL-8 (PDB: 1IL8) using
combinatorial extension (Shindyalov and Bourne). Abbreviations: RMSD, root
mean square deviation (calculated between α-carbons); Z, z-score; Aln, number
of residues aligned; Gap, gaps inserted for alignment; % ID, percent sequence
identity with IL-8 over aligned region. Note that molecules are listed in
ascending RMSD rank order.whether IL-8α interacts with membranes in a manner similar to
classical α-helical antimicrobial peptides.
Guided by similarities to other kinocidins such as platelet
microbicidal proteins [4,8], we previously identified direct and
pH-related antimicrobial activity of full-length human IL-8 in
vitro [4,8,12,13]. Meritorious prior studies did not detect
antimicrobial activity of IL-8 or MCP-1 against bacteria
[10,11], and their antifungal activity has not been shown
previously. Thus, the present results provide new information,
including demonstration of direct microbicidal efficacies of IL-
8 and IL-8α, with potent fungicidal activity versus C. albicans.
The ability to detect IL-8 antimicrobial efficacy in the current
studies may be due to a number of factors, including organism
and/or strain differences, as well as buffer composition and pH.
Fig. 7. Computational modeling of IL-8 structural domains. Three-dimensional
models of IL-8γKC (A) and IL-8α (B) peptides were created using homology and
energy-based methods. Model peptide alpha-carbon backbones were visualized
using PyMOL (version 0.97; 2004).
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against different organisms (E. coli or Listeria monocyto-
genes), and did not assess activity at pH 5.5 [10]. In the one
prior study using a solution-phase assay, activity of IL-8 was
evaluated against E. coli and S. aureus using a phosphate-
based buffer system at pH 7.4 [11]. Results from these latter
experiments corroborate the present finding that native IL-
8 lacks activity against S. typhimurium or S. aureus in solution
phase at pH 7.5.
One limitation to understanding the relevance of antimi-
crobial peptides is the need to determine their efficacy in
biologically relevant settings. Importantly, the present data
demonstrate previously unrecognized efficacy of the IL-8α
motif in human blood matrices. In this complex environment,
IL-8α was highly efficacious against E. coli at concentrations
as low as 1–5 μg /ml, with microbicidal activity at
concentrations of 10 μg /ml or more in blood. These
discoveries are significant for several reasons. First, they
substantiate the concept that autonomous kinocidin fragments
exert microbicidal efficacy in relevant contexts. Second, IL-
8α has durable efficacy, since it exhibited microbicidal
efficacy in serum fractions on co-incubation, and retained
activity in blood matrices even after 2 h of pre-incubation
before addition of the target pathogen. Prior studies with
many antimicrobial peptides suggest substantial reductions in
efficacy, inactivation in serum, or lack of efficacy in animal
models [47,48]. Thus, the present data provide importantnew insights toward understanding the direct antimicrobial
roles of IL-8 or related kinocidins in relevant contexts in
vivo.
Several lines of evidence support the concept that kinocidins
exert direct antimicrobial activity in specific contexts in the
host. For example, in normal human plasma, IL-8 is present at a
very low baseline level in the range of pg/ml [49]. However, in
acute contexts of infection, IL-8 levels can rise 1000-fold,
reaching concentrations of 30–50 ng/ml [49]. In the current
report, IL-8α exerted substantial activity in blood matrices in the
range of 50–500 ng/ml, a level consistent with that measured in
vivo. Likewise, recent studies by Qiu et al. show that the
chemokine CCL22/MDC intensifies to similar levels in lung
granulomae [50]. Moreover, as they adhere to pathogens, α-
helical peptides derived from kinocidin-like holoproteins
accumulate at sites of infection even after systemic administra-
tion [51]. Thus, measurements of their free concentration in
media or sera almost certainly underestimate their local
intensification [52]. Likewise, in sites of infection or inflam-
mation (e.g. interstitial fluids, abscess exudates, serum, or
mucosa), and in leukocyte phagolysosomes [53], pH can be
significantly lower than that of plasma. The fact that many
kinocidins, including IL-8 and IL-8α have enhanced antimicro-
bial efficacy at pH 5.5 versus pH 7.5 is consistent with these
concepts.
In summary, the novel findings define γ-core motifs in
kinocidins, characterize structural and conditional correlates of
kinocidin microbicidal activity, and demonstrate relevant
microbicidal efficacy of IL-8α in human blood matrices. This
evidence supports the concept that kinocidins or their modules
provide direct microbicidal efficacy in relevant physiological
contexts [12], complementing their chemoattractant roles,
thereby coordinating molecular and cellular host defenses.
Together, these new insights support a reassessment of host
defense functions traditionally ascribed to chemokines.
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